PRECISION: BLOOD CANCER
Online this year (Sep 29/30). Click below to be directed to the virtual agenda for 2021:
VIRTUAL EVENT
SCOPE OF THE MEETING
Blood Cancer accounts for 10% of new cancer cases diagnosed in the US. Approximately every 3 minutes one person is diagnosed and every 9 minutes one person dies.
Blood cancer R&D is experiencing rapid growth, representing an enormous opportunity for drug developers, driven by Innovative Cancer Treatment Therapies
The global market for Blood cancer therapeutics, valued at $24 billion in 2015, is poised to reach $38 billion by 2020, expanding by a CAGR of 9.7%
Do You Have the Latest Insights to Transform the Success of Your Pipeline?
The 3rd Annual Precision: Blood Cancer will bring together scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.
Discussions will revolve around translating the latest developments in the genomic and molecular understanding of the disease into new targeted therapies in the clinic.
HIGHLIGHTS
CAR-TCR
CHECKPOINT INHIBITORS
ANTIBODY CONSTRUCTS
BIOMARKERS
COMPANION DIAGNOSTICS
34%
26%
12%
12%
9%
7%
Large Drug Developers
Small & Mid-Sized Developers
Academia
& Hospitals
CROs &
Platform Technology
Equipment
Providers
Other
COMPANY TYPE
%
JOB TITLE
%
VP, Director, Head
C-Level
Scientists
Managers
48%
23%
18%
11%
GOALS OF THE EVENT
Learning Objectives
Target Audience
FEATURED SPEAKERS
Past Speakers
NATALIE BEZMAN
Director, Immuno-Oncology Discovery
Bristol-Myers Squibb
LOUI MADAKAMUTIL
SVP, Head of Discovery and Preclinical Development
Nektar Therapeutics
VICKI PLAKS
Principal Scientist, CAR-T Cell Immunotherapy, Translational Medicine, Kite Pharma / Gilead
CYRIL KONTO
VP, Clinical Development
Allogene
AN SONG
SVP, Development Sciences
Immune-Onc Therapeutics
PIETRO TAVERNA
Exec. Director, Translational Medicine
Sunesis Pharmaceuticals
MARK STERN
Director, Precision Medicine & Companion Diagnostics
Celgene
THOMAS TAN
Vice President, Immunology
Elstar Therapeutics
VIEW FULL AGENDA
DOWNLOAD PDF
DOWNLOAD OUR EVENT GUIDE
7 Pages Of Content, Produced In Collaboration With Our Advisory Board
TICKET OPTIONS
Choose The Correct Ticket - Group Rates Available
INDUSTRY DELEGATE
Early Bird expires August 23, 2019 (Standard rate $2199)
Pharma & Biotech Drug Developers / Solution Providers.
Access to 2-day Conference & Networking Sessions
$1899
(Save $300)
EXPIRED
ACADEMIC DELEGATE
Early Bird expires August 23, 2019 (Standard rate $799)
Reserved for Non-Profit Organizations.
Access to 2-day Conference & Networking Sessions
$599
(Save $200)
EXPIRED
SPONSORS
Past Sponsors:
OTHER EVENTS
The annual Precision: Blood Cancer summit is part of a Four-indication Oncology R&D Networking series organized since 2015 by Neo-Synth Ltd.
VENUE
Our Event is Hosted at:
Crowne Plaza San Francisco Airport
1177 Airport Blvd, Burlingame, CA 94010, USA
DOWNLOAD EVENT GUIDE
Complete the form below to download the PDF
NEO SYNTH Ltd. 8-13 St Pancras Way, London, NW1 0QG
contact@neo-synth.com
(+1) 617.500.5172
Your details will not be shared with a third party
CONNECT!
Follow Our Latest News on Twitter
Copyright © 2019 | All content produced by: Neo-Synth Ltd.